RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Medication related self-efficacy among linguistically diverse patients with chronic illnesses
Zhang, Y., Solomon, C., Moreno, G., Chang, E., Lin, E. H., Johnson, R. L., Berthoud, H., & Morales, L. S. (2018). Medication related self-efficacy among linguistically diverse patients with chronic illnesses. Journal of Health Care for the Poor and Underserved, 29(3), 1054-1068. https://doi.org/10.1353/hpu.2018.0079
This study examines medication-related self-efficacy in a linguistically diverse group of patients with diabetes, hypertension, and elevated cholesterol. A telephone survey of 509 adults conducted in six languages (English, Spanish, Korean, Vietnamese, Mandarin, and Cantonese) was analyzed. Self-efficacy was assessed with the overall Medication Understanding and Use Self-Efficacy (MUSE) score and its two subscale scores on taking medication and learning about medications. Compared with English proficient (EP) patients, patients with limited English proficiency (LEP) had a lower mean learning self-efficacy subscale score (LEP: 14.5, EP: 15.4; p<.001) and no difference in the mean taking self-efficacy subscale score (LEP: 14.4, EP: 14.6; p=.40). Receiving verbal medication information (VMI) from providers modified the relationship between LEP status and learning self-efficacy. In conclusion, among patients with chronic illnesses, LEP patients had lower medication-related self-efficacy scores than EP patients, which may put them at greater risk for medication taking errors and lower adherence.